- Home
- OPHC vs OSTX Comparison
OPHC vs OSTX Comparison
Compare OPHC & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPHC
- OSTX
- Stock Information
- Founded
- OPHC 2000
- OSTX 2018
- Country
- OPHC United States
- OSTX United States
- Employees
- OPHC N/A
- OSTX N/A
- Industry
- OPHC Major Banks
- OSTX
- Sector
- OPHC Finance
- OSTX
- Exchange
- OPHC Nasdaq
- OSTX NYSE
- Market Cap
- OPHC 43.1M
- OSTX 43.0M
- IPO Year
- OPHC N/A
- OSTX 2024
- Fundamental
- Price
- OPHC $4.37
- OSTX $1.81
- Analyst Decision
- OPHC
- OSTX Strong Buy
- Analyst Count
- OPHC 0
- OSTX 3
- Target Price
- OPHC N/A
- OSTX $18.00
- AVG Volume (30 Days)
- OPHC 9.1K
- OSTX 301.8K
- Earning Date
- OPHC 08-05-2025
- OSTX 08-14-2025
- Dividend Yield
- OPHC N/A
- OSTX N/A
- EPS Growth
- OPHC 30.24
- OSTX N/A
- EPS
- OPHC 1.33
- OSTX N/A
- Revenue
- OPHC $39,980,000.00
- OSTX N/A
- Revenue This Year
- OPHC N/A
- OSTX N/A
- Revenue Next Year
- OPHC N/A
- OSTX N/A
- P/E Ratio
- OPHC $3.30
- OSTX N/A
- Revenue Growth
- OPHC 53.28
- OSTX N/A
- 52 Week Low
- OPHC $3.53
- OSTX $1.12
- 52 Week High
- OPHC $5.90
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- OPHC 48.76
- OSTX N/A
- Support Level
- OPHC $4.36
- OSTX N/A
- Resistance Level
- OPHC $4.62
- OSTX N/A
- Average True Range (ATR)
- OPHC 0.07
- OSTX 0.00
- MACD
- OPHC -0.01
- OSTX 0.00
- Stochastic Oscillator
- OPHC 32.90
- OSTX 0.00
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides a range of community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal account, money market deposit accounts, debit cards, and automated teller machines.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.